Crossmark

Associations of common mental disorder severity with treatment contact and treatment intensity, and its changes over twelve years

Published Online: 2025-03-11

Published Print: 2025-09

Authors

Nuyen, J. https://orcid.org/0000-0002-4029-6219
van Dorsselaer, S. https://orcid.org/0000-0002-1253-2202
Tuithof, M. https://orcid.org/0000-0002-5802-3913
Luik, A. I. https://orcid.org/0000-0001-7517-197X
Kroon, H. https://orcid.org/0000-0002-2259-1628
Have, M. ten https://orcid.org/0000-0003-0086-2199
License Information

Text and Data Mining valid from 2025-03-11

Version of Record valid from 2025-03-11
More Information

Article History

Received: 12 May 2024

Accepted: 23 February 2025

First Online: 11 March 2025

Declarations

:

: For NEMESIS-3, the Medical Research Ethics Committee (METC Utrecht) stated that the Dutch Medical Research Involving Human Subjects Act (WMO) did not apply (reference number: WAG/mb/19/017126; May 15, 2019). Therefore, no official approval was required under the WMO. The field procedures, information for respondents and informed consent forms were assessed positively by the local ethical review committee. NEMESIS-2 was approved by a medical ethics committee (the Medical Ethics Review Committee for Institutions on Mental Health Care, METiGG; reference number: CCMO/NL18210.097.07), since it included saliva collection. In both studies, respondents provided written informed consent, after full written and verbal information about the study was given before and at the start of the interview.

: The authors declare no competing interests.

Document is current